Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: (PTSC.OB) Corporate Event Announcement Notice

All we really know about Crossflo is that theyhad 20MM in rev's; we have never been told if they had any earnings whatsoever, so I wouldn't expect anything from them on our Q. Besides our q ended in August and we didn't acquire them totally till around 8/30-9/1 or so. Next q we will see something (plus or minus) probably, but even then it would have to be listed as a separate net item on our Q to discern even that.

Share
New Message
Please login to post a reply